AGA patients often exhibit overexpression of insulin-like growth factor 1 (IGF-1), which inhibits the mitogen-activated protein kinase (MAPK) signaling pathways, resulting in the shrinkage of HFs and blood vessels. Here, IGF1 is linked to Hand-foot syndrome.